Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease...
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment
Real-World Effectiveness and Safety of Tofacitinib in Crohn's Disease and IBD-U
Safety and efficacy of combining biologics or small molecules for IBD
Malnutrition and sarcopenia are prevalent among inflammatory bowel disease patients
Fecal and mucosal microbiota profiling in pediatric inflammatory bowel diseases
Review Article: vaccination for patients with inflammatory bowel disease during the COVID-19
Diagnostic Accuracy of Fecal Calprotectin Concentration in Evaluating Therapeutic Outcomes
Efficacy of Vitamin B6 Supplementation on Inflammatory Markers, Serum Homocysteine level
Comparison of Interferon-Gamma Release Assay and Tuberculin Skin Test